Home/Filings/4/0001214659-19-000538
4//SEC Filing

CHEN ISAN 4

Accession 0001214659-19-000538

CIK 0001576263other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 7:00 PM ET

Size

14.2 KB

Accession

0001214659-19-000538

Insider Transaction Report

Form 4
Period: 2019-01-23
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-23$24.99/sh+244$6,09835,210 total
  • Exercise/Conversion

    Common Stock

    2019-01-23$21.51/sh+625$13,44435,835 total
  • Exercise/Conversion

    Common Stock

    2019-01-23$5.40/sh+1$535,836 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-01-2362525,283 total
    Exercise: $21.51Exp: 2025-02-03Common Stock (625 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-01-23149,997 total
    Exercise: $5.40Exp: 2027-01-25Common Stock (1 underlying)
  • Exercise/Conversion

    Stock Options

    2019-01-2324459,756 total
    Exercise: $24.99Exp: 2026-01-21Common Stock (244 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001586218

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 7:00 PM ET
Size
14.2 KB